Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
AddLife Community
OM:ALIF B Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
AddLife
Popular
Undervalued
Overvalued
Community Investing Ideas
AddLife
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Adoption Of AI And Robotics Is Expected To Drive Future Success In Medtech
Key Takeaways Continued efficiency initiatives and product optimization are expected to improve profitability and net margins by focusing on high-margin products. Strategic acquisitions and adoption of advanced technologies position AddLife for revenue growth and increased market presence in high-growth areas.
View narrative
SEK 175.50
FV
2.7% undervalued
intrinsic discount
5.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
ALIF B
ALIF B
AddLife
Your Fair Value
SEK
Current Price
SEK 170.80
41.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
14b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 13.7b
Earnings SEK 406.5m
Advanced
Set Fair Value